Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HypoVereinsbank (HVB), officially UniCredit Bank GmbH, is a leading German financial institution headquartered in Munich and a primary subsidiary of the Italian UniCredit Group. While the bank is not a biotechnology or healthcare company, it maintains a specialized Healthcare & Pharma industry team that provides tailored financial services, including corporate lending, M&A advisory, and capital markets support to the life sciences sector. HVB serves a broad range of clients, from retail customers to large multinational corporations and the German 'Mittelstand.' The bank is a key player in the European banking sector, focusing on commercial and investment banking services across Germany. It was formed through the 1998 merger of Bayerische Vereinsbank and Bayerische Hypotheken- und Wechsel-Bank.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HypoVereinsbank.